You did everything the same. Same meals. Same movement. Same routine. Somewhere around 40, it stopped working. The weight crept on. The energy disappeared. Sleep fell apart. Your doctor said your bloods were fine.
Then someone mentioned Ozempic.
If you're a woman in perimenopause taking or considering Ozempic, there are things you need to know that most prescribers aren't discussing.
Why perimenopause changes everything about weight loss
The hormonal shifts that begin in your late 30s and accelerate through your 40s fundamentally change how your body stores and processes fat. Declining oestrogen reduces insulin sensitivity. Progesterone fluctuations affect water retention, appetite, and sleep. Cortisol runs higher, driving fat storage around the middle. And natural muscle loss accelerates as oestrogen's protective effect wanes.
This isn't a failure of discipline. It's a shift in biology.
Declining oestrogen
Reduces insulin sensitivity, accelerates muscle loss, increases fat storage — particularly around the abdomen.
Progesterone fluctuations
Affect water retention, appetite regulation, and sleep quality — all of which directly impact weight and metabolism.
Higher cortisol
Chronic stress and poor sleep drive cortisol up, which promotes fat storage around the middle and increases cravings.
Accelerated muscle loss
Oestrogen has a protective effect on muscle tissue. As it declines, muscle loss speeds up — lowering metabolic rate.
Ozempic works — but the context matters
Ozempic (semaglutide) is approved for type 2 diabetes, though it's widely prescribed off-label for weight management. For perimenopausal women, it can be effective at reducing appetite and producing weight loss. Post hoc analysis of the SURMOUNT trials showed that women achieved similar weight reduction regardless of menopausal status, and semaglutide data shows comparable patterns.
But Ozempic's typical dose range (0.5–2mg weekly) is lower than Wegovy's weight management dose (2.4mg). Some women find the appetite suppression at Ozempic doses less dramatic — which can actually be an advantage: more moderate appetite reduction means it's easier to maintain adequate protein intake and nutrition quality.
“The question worth asking isn't just ‘is this working?’ It's ‘what am I building underneath it?’”
The risks that matter most for women over 40
01
Muscle loss
You're already losing muscle naturally with declining oestrogen. Adding a medication that suppresses appetite can accelerate this if protein intake drops. Resistance training and 1.2–1.6g protein per kg body weight daily are essential, not optional.
Read more about GLP-1 and muscle loss02
Bone density
Rapid weight loss from any cause can reduce bone mineral density. Oestrogen decline is already increasing your osteoporosis risk. Weight-bearing exercise becomes even more important — not just for muscle, but for bone.
03
Sleep disruption
Perimenopause already disrupts sleep. Poor sleep directly undermines everything Ozempic is trying to do by increasing hunger hormones, insulin resistance, and cortisol. Addressing sleep quality is foundational, not secondary.
04
GI side effects
Hormonal fluctuations already affect gut motility. Adding a medication that slows gastric emptying can amplify nausea, bloating, and constipation. Start low, increase slowly, and don't rush the titration.
What good support looks like
A prescription is the start. What happens alongside it determines whether the results last. Adequate protein. Resistance training. Sleep addressed as a priority. Body composition monitored, not just weight. An exit plan for when or if you stop.
If you're a woman in perimenopause on Ozempic, the question worth asking isn't just “is this working?” It's “what am I building underneath it?”
Related reading
On Ozempic in perimenopause and want proper support?
I work specifically with women in midlife navigating the intersection of hormonal change and metabolic health — including GLP-1 medications. Book a free 30-minute consultation to talk through where you are.
Book a free consultation
